Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 650 of 6351
-
Ear-Worn gadget aims to predict seizures before they start
Diagnosis Recruiting nowThe proposed study is an investigator-initiated study that aims to measure the accuracy of a wearable seizure detection and prediction device (Ear-Seizure Detection Device (EarSD)) by simultaneous recording with conventional video-EEG (Electroencephalogram) on patients with epile…
Sponsor: Felicia Chu • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Could a diabetes drug stop AFib from coming back?
Disease control Recruiting nowObjective: The purpose of this study is to determine if there is a difference in the recurrence rate of atrial fibrillation (AF) between a group of patients with AF and heart failure undergoing catheter ablation who are administered the SGLT2 inhibitor, Enavogliflozin, and a cont…
Phase 4 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis is a single-arm, open-label, exploratory clinical study to evaluate the safety and preliminary efficacy of Anti-HER2 CAR-T cell injection in patients with HER2-positive advanced malignant solid tumors.
Sponsor: UTC Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New combo therapy aims to control advanced breast cancer
Disease control Recruiting nowPhase I: Characterize safety and tolerability of ECI830 as a single agent and in combination with ribociclib and fulvestrant. Identify dose range for optimization/recommended dose for future studies. Phase II: Assess the anti-tumor activity of ECI830 in combination with ribocicl…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New combo may help more lymphoma patients reach potentially curative CAR-T
Disease control Recruiting nowThis phase II trial tests the effectiveness of golcadomide and rituximab as bridging treatment before chimeric antigen receptor (CAR) T-cell therapy in patients with aggressive B-cell non-Hodgkin lymphoma that has come back after a period of improvement (relapsed) or that has not…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New scan could spot cancer spread sooner, boosting survival
Knowledge-focused Recruiting nowSeveral studies have shown improved sensitivity of FDG-PET/CT compared with conventional imaging for diagnosing metastatic breast cancer in retrospective and smaller prospective studies. For response monitoring, we expect FDG-PET/CT to detect disease progression earlier than CT i…
Sponsor: Odense University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New hope for Hard-to-Treat nasopharyngeal cancer: targeted drug HLX43 enters phase 2 trial
Disease control Recruiting nowThe study is to explore the reasonable dosage and to evaluate the efficacy, safety and tolerability of HLX43 (Anti-PD-L1 ADC) in patients with recurrent/metastatic Nasopharyngeal Carcinoma (NPC) who failed or are intolerant to second-line herapy.
Phase 2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug duo aims to outsmart tough lymphoma
Disease control Recruiting nowThis phase Ib/II trial evaluates the safety, optimal dose, and efficacy of the combination of epcoritamab and ibrutinib in treating patients with aggressive B-cell non-Hodgkin lymphoma that has come back (relapsed) or responded to previous treatment (refractory). Epcoritamab, a b…
Phase 1/2 • Sponsor: Yazeed Sawalha • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Chemo fog inside the belly: could PIPAC boost ovarian cancer surgery success?
Disease control Recruiting nowThe goal of this clinical trial is to learn whether repeated cisplatin-based PIPAC added to standard TC chemotherapy can improve outcomes in women aged 18-75 years with newly diagnosed FIGO IIIB-IIIC epithelial ovarian cancer and visually detectable peritoneal carcinomatosis. The…
Phase 2 • Sponsor: Moscow Regional Oncological Dispensary • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a single gene therapy injection hold back wet AMD for years?
Disease control Recruiting nowThis is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All subject who completed the parent clinical study (NCT06213038 and NCT05986864) wil…
Sponsor: Skyline Therapeutics • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Engineered immune cells take on lupus in early trial
Disease control Recruiting nowThis investigator-initiated trial aims to evaluate the safety and efficacy of universal anti-CD70 CAR-T (CHT101) in patients with relapsed refractory systemic lupus erythematosus.
Early phase 1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug cocktail aims to tame deadly transplant complication
Disease control Recruiting nowThe purpose of this study is to assess Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Glow-in-the-Dark dye could help surgeons remove all prostate cancer
Diagnosis CompletedThis study is being done to compare how well Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent imaging may improve the detection of malignant (growing in an uncontrolled way) tissue in adult subjects undergoing prostatectomy and lymph node dissection for bio…
Phase 2 • Sponsor: Clinton Bahler • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Sound waves vs. superbugs: can a simple ultrasound curb unnecessary antibiotics in kids?
Disease control Recruiting nowTitle: Effect of Pediatric Lung Ultrasound on Antibiotic Prescriptions in Hospitalized Children and Adolescents with Lower Respiratory Tract Infections (PLUS-AP Trial) Purpose of the Study: This study is being done to find out if a type of imaging called lung ultrasound (LUS) c…
Sponsor: American University of Beirut Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a smartphone app boost daily functioning for veterans in opioid recovery?
Symptom relief Recruiting nowOpioid Use Disorder (OUD) is a complex, chronic condition affecting nearly 70,000 Veterans who can experience significantly reduced quality of life (e.g., poorer social, occupational, and health-related functioning). VA clinics providing Medication treatment for OUD (MOUD); e.g.,…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Can a common white blood cell booster shield the brain from Chemo-Radiation damage?
Disease control Recruiting nowThis research study involves the study of granulocyte colony stimulating factor (G-CSF) in patients with MGMT-methylated glioblastoma multiforme (GBM) that are undergoing standard chemoradiation. The study aims to evaluate G-CSF's effects on brain health and cognitive function. …
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Nerve-Stretching technique may ease sciatica pain — trial puts it to the test
Symptom relief CompletedThe objective of this randomized controlled clinical trial is to evaluate whether manual therapy combined with neural mobilization can improve pain, functional impairment, quality of life, inflammatory markers, and infrared thermographic findings in patients with lumbar disc hern…
Sponsor: Longhua Hospital • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New shunt procedure could extend life for liver patients
Disease control Recruiting nowThe aim of this clinical trial is to compare the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) implantation with standard treatment (diuretic medications, and if necessary, paracenteses) in patients with liver cirrhosis and development of ascites as …
Sponsor: University Hospital Freiburg • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a higher dose of this pill regrow hair in severe alopecia?
Disease control Recruiting nowThe purpose of the study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the treatment of alopecia areata. Alopecia areata is a disease that causes hair loss on the scalp, face, and areas of the body. Ritlecitinib is approved in many coun…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Which surgery is safer for a dangerous placenta condition?
Disease control CompletedPlacenta accreta rates are rising alongside the rising rates of caesarean deliveries. This has lead to a vast number of studies negotiating the histopathological nature, risk factors and outcomes of pregnancies complicated with placenta accreta. In the study the investigators re …
Sponsor: Cairo University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC